Hepatitis B and the liver cancer endgame
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Nature 603, S64-S65 (2022)
This article is part of Nature Outlook: Hepatitis B, an editorially independent supplement produced with the financial support of third parties. About this content.
Lee, W. Y., Bachtiar, M., Choo, C. C. S. & Lee, C. G. Biol. Rev. Camb. Philos. Soc. 94, 353–367 (2019).
lvarez, E. G. et al. Nature Commun. 12, 6910 (2021).
Behary, J. et al. Nature Commun. 12, 187 (2021).
Zeng, Y. et al. J. Viral Hepat. 27, 143–155 (2020).
Liu, Q. et al. Gut Pathog. 11, 1 (2019).
Sofi, F., Abbate, R., Gensini, G. F. & Casini, A. Am. J. Clin. Nutr. 92, 1189–1196 (2020).
George, E. S. et al. Nutrients 13, 172 (2021).
Toy, M. et al. Clin. Infect. Dis. 74, 210–217 (2022).